Biotech · Private company
Rexahn Pharmaceuticals, Inc.
Track this companyFree. Adds Rexahn Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- RX-0201Phase 2 · Metastatic Renal Cell CancerClinicalTrials.gov · fetched Nov 12, 2026
- RX-0201 plus GemcitabinePhase 2 · Metastatic Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- RX-5902Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell CancerPHASE1_PHASE2 · TERMINATED · started Aug 1, 2014ClinicalTrials.gov NCT02089334 · fetched Nov 12, 2026
- RX-5902 Treatment of Subjects With Triple Negative Breast CancerPHASE1_PHASE2 · TERMINATED · started Aug 1, 2013ClinicalTrials.gov NCT02003092 · fetched Nov 12, 2026
- A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic CancerPHASE2 · COMPLETED · started May 1, 2009ClinicalTrials.gov NCT01028495 · fetched Nov 12, 2026